CLINICAL_TRIALS trial_result · 2017-12-13

Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma [Phase 2]

Phase 2 clinical trial of antineoplaston therapy for low-grade astrocytoma; the study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Burzynski Research Institute | Conditions: Low-Grade Astrocytoma, Nos | Phase 2 | Status: TERMINATED | Results posted: 2017-12-13